One of the top-performing thematic segments this year is cannabis. A major catalyst has been the proposed descheduling of it from a Schedule I to a Schedule III drug under the Controlled Substances Act (CSA). That means it would be reclassified into a lower category below hard drugs like heroin and cocaine. Back in August, [...] The post Understanding Cannabis ETFs’ Wacky Divergence appeared first on ETF Trends .